Morphosys Pairs Antibody Platform with Sloning's

Oct. 8, 2010

By Catherine Hollingsworth

NewCo News: Tivorsan Ready to Raise Funds for Biglycan DMD Candidate

Oct. 7, 2010

By Catherine Hollingsworth

Cyclacel Seeks to Raise $22M for Phase III-Ready AML Drug

Oct. 6, 2010

By Catherine Hollingsworth

SPA in Hand, Onconova Moves Estybon into MDS Phase III

Oct. 5, 2010

By Catherine Hollingsworth

AVEO Regains Rights to Phase II Antibody AV-299

Oct. 1, 2010

By Catherine Hollingsworth

MAP Raising $40.9M as Levadex Heads Toward NDA

Sep. 30, 2010

By Catherine Hollingsworth

Researcher's Pet Project Leads to Eye Therapy, Lasker Prize

Sep. 29, 2010

By Catherine Hollingsworth

VaxDesign to be Acquired by Sanofi Pasteur in $60M Deal

Sep. 28, 2010

By Catherine Hollingsworth

Cylene Adds $12M to Top Off Substantial Series C Round

Sep. 24, 2010

By Catherine Hollingsworth

Sanofi-Vical's Gene Therapy Flames Out in Phase III Trial

Sep. 23, 2010

By Catherine Hollingsworth